Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “antiPLA2R Positive”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Study completedNCT04145440
What this trial is testing

Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)

Who this might be right for
Glomerulonephritis, MembranousantiPLA2R Positive
HI-Bio, A Biogen Company 31
Testing effectiveness (Phase 2)Study completedNCT04733040
What this trial is testing

Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)

Who this might be right for
GlomerulonephritisMembranous NephropathyantiPLA2R Positive
HI-Bio, A Biogen Company 24

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation